ロード中...
Genomic Profiling for KRAS, NRAS, BRAF, Microsatellite Instability, and Mismatch Repair Deficiency Among Patients With Metastatic Colon Cancer
PURPOSE: Genomic testing is recognized in national guidelines as essential to guide appropriate therapy selection in metastatic colorectal cancer. Previous studies report adherence to testing guidelines is suboptimal, but current testing rates have not been assessed. This study reports testing rates...
保存先:
| 出版年: | JCO Precis Oncol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Clinical Oncology
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7448804/ https://ncbi.nlm.nih.gov/pubmed/32923867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.19.00274 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|